Kate E. Broderick
Impact in
- Virology top 2%
- HIV Research and Treatment
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in ⓘ
-
- Transgenic Plants and Applications 25
- Microbial Inactivation Methods 23
- Virology 15
- HIV Research and Treatment 11
- Co-authors
- Niranjan Y. Sardesai (40 shared papers)Shireen A. Davies (8 shared papers)Julian A. T. Dow (8 shared papers)David B. Weiner (27 shared papers)Laurent Humeau (16 shared papers)Laura Kean (5 shared papers)Amir Sada Khan (14 shared papers)Trevor R.F. Smith (24 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (14 papers)Vaccine (8 papers)Human Gene Therapy (4 papers)Human Gene Therapy Methods (4 papers)PLoS ONE (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kate E. Broderick
93 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 114
- Virology 289
- Immunology 925
- Biotechnology 340
- Infectious Diseases 539
- Aging 45
Countries citing papers authored by Kate E. Broderick
This map shows the geographic impact of Kate E. Broderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate E. Broderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate E. Broderick more than expected).
Fields of papers citing papers by Kate E. Broderick
This network shows the impact of papers produced by Kate E. Broderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate E. Broderick. The network helps show where Kate E. Broderick may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate E. Broderick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 229 | |
| 2 | 2002 | 178 | |
| 3 | 2002 | 125 | |
| 4 | 2005 | 98 | |
| 5 | 2006 | 63 | |
| 6 | 2013 | 62 | |
| 7 | 2001 | 61 | |
| 8 | 2005 | 58 | |
| 9 | 2015 | 56 | |
| 10 | 2012 | 54 | |
| 11 | 2017 | 52 | |
| 12 | 2010 | 50 | |
| 13 | 2014 | 50 | |
| 14 | 2018 | 49 | |
| 15 | 2011 | 45 | |
| 16 | 2013 | 45 | |
| 17 | 2012 | 44 | |
| 18 | 2014 | 44 | |
| 19 | 2013 | 44 | |
| 20 | 2020 | 42 |
About Kate E. Broderick
Kate E. Broderick is a scholar working on Biotechnology, Virology, Immunology, Infectious Diseases and Pharmaceutical Science, having authored 93 papers that have together received 2.7k indexed citations. Recurring topics across this work include Transgenic Plants and Applications (25 papers), Microbial Inactivation Methods (23 papers), Immunotherapy and Immune Responses (17 papers), Toxin Mechanisms and Immunotoxins (15 papers), HIV Research and Treatment (11 papers), Virus-based gene therapy research (8 papers), Neurobiology and Insect Physiology Research (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Virology (289 citations), Immunology (925 citations), Biotechnology (340 citations), Infectious Diseases (539 citations) and Aging (45 citations). Kate E. Broderick has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Niranjan Y. Sardesai, Shireen A. Davies, Julian A. T. Dow, David B. Weiner, Laurent Humeau, Laura Kean, Amir Sada Khan, Trevor R.F. Smith, Valerie P. Pollock and Jian Yan. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Vaccine, Human Gene Therapy, Human Gene Therapy Methods and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.